Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) was the target of some unusual options trading activity on Thursday. Bicycle Therapeutics Price PerformanceBicycle Therapeutics stock opened at $8.53 on Friday. Bicycle Therapeutics had a negative net margin of 1,257.00% and a negative return on equity of 32.43%. Equities analysts anticipate that Bicycle Therapeutics will post -3.06 earnings per share for the current fiscal year. Featured ArticlesReceive News & Ratings for Bicycle Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bicycle Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.